Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
¥411.00 - ¥2.48K
Next Earnings Date
Jun 11 2025 (Estimate)
Next Earnings Date
Jun 11 2025 (Est.)
Latest price
Market Cap | ¥136.68B |
EV | ¥134.16B |
Shares Outstanding | 72.01M |
Beta | -0.08 |
Analyst Rating | UNDERPERFORM |
Analyst Target Price | ¥1320.00 |
P/E 2026E | - |
P/Revenue 2026E | 87.25x |
Revenue | - |
EPS | 22.60% |
Operating Cash Flow | 18.10% |
Free Cash Flow | 31.10% |
Revenue | - |
EPS | 3.20% |
Operating Cash Flow | - |
Free Cash Flow | -3.20% |
Gross Margin 2026E | 70.00% |
Net Profit Margin 2026E | -131.40% |
ROE 2026E | 15.32% |
ROCE 2025 | -126.57% |
DPS 2026E | ¥0.00 |
Payout Ratio 2026E | 0.00% |
Div. Yield 2026E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
SanBio Company Limited
4592
Sector
Healthcare
Industry
Biotechnology
CEO
Mori, Keita
Employees
29
Website
www.sanbio.comIPO Date
2015-04-08
Headquarters
St. Luke Tower, 13th Floor, 8-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved